Antihypertensive agents for dialysis patients

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Rabindranath, Kannaiyan S ^a   MacLeod, Alison M ^b   Tellez, David ^c   Munarriz, Cesar Loza ^c  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CILAZAPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; EPROSARTAN; FOSINOPRIL; IMIDAPRIL; INDORAMIN; IRBESARTAN; LISINOPRIL; METHYLDOPA; MOEXIPRIL; MOXONIDINE; PERINDOPRIL; PHENTOLAMINE; PRAZOSIN; QUINAPRIL; RAMIPRIL; TERAZOSIN; UNINDEXED DRUG; VASODILATOR AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DATA ANALYSIS; DATA EXTRACTION; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 70249150672     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007670     Document Type: Review

References (28)

1. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment and control of hypertension in chronic hemodialysis patients in the United States. American Journal of Medicine 2003;115(4):291-297 [MEDLINE: 12967694] (Pubitemid 37088191)
2. Bennett WM, McDonald WJ, Kuehnel E, Hartnett MN, Porter GA. Do diuretics have antihypertensive properties independent of natriuresis?. Clinical Pharmacology & Therapeutics 1977;22(5 Pt 1):499-504. [MEDLINE: 334435] (Pubitemid 8225562)
3. Chan MK, Baillod RA, Chuah P, Sweny P, Raftery MJ, Varghese Z, et al.Three years' experience of continuous ambulatory peritoneal dialysis. Lancet 1981;1(8235):1409-1412 [MEDLINE: 6113364] (Pubitemid 11117791)
4. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, et al.Survival as an index of adequacy of dialysis. Kidney International 1992;41(5):1286-1291 [MEDLINE: 1614043]
5. Foley RN, Herzog CA, Collins AJ, United States Renal Data System. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 study. Kidney International 2002;62(5):1784-1790 [MEDLINE: 12371980]
6. Griffith TF, Chua BS, Allen AS, Klassen PS, Reddan DN, Szczech LA. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. American Journal of Kidney Diseases 2003;42(6):1260-1269 [MEDLINE: 14655199]
7. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA 2003;290(2):199-206. [MEDLINE: 12851274]
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560 [MEDLINE: 12958120]
9. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. 2008. Available from www.cochrane-handbook.org.
10. Kooman JP, Gladziwa U, Bocker G, Wijnen JA, Bortel L, Luik AJ, et al.Blood pressure during the interdialytic period in haemodialysis patients: estimation of representative blood pressure values. Nephrology Dialysis Transplantation 1992;7(9):917-923 [MEDLINE: 1328939]
11. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochrane-handbook.org.
12. United States Cochrane Center. Master list of journals being searched. http://apps1.jhsph.edu/cochrane/masterlist.asp (accessed May 2007).
13. Mittal SK, Kowalski E, Trenkle J, McDonough B, Halinski D, Devlin K, et al.Prevalence of hypertension in a hemodialysis population. Clinical Nephrology 1999;51(2):77-82. [MEDLINE: 10069642]
14. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, et al.Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. American Journal of Kidney Diseases 1999;33(3):507-517 [MEDLINE: 10070915]
15. Willis NS, Mitchell R, Higgins GY, Webster AC, Craig JC. Cochrane Renal Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2008, Issue 1. Art. No.: RENAL (accessed March 2008).
16. Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. American Journal of Kidney Diseases 1993;21(5 Supp 2):113-118 [MEDLINE: 8494009] (Pubitemid 23158809)
17. Rocco MV, Flanigan MJ, Beaver S, Frederick P, Gentile DE, McClellan WM, et al.Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group. American Journal of Kidney Diseases 1997;30(2):165-173 [MEDLINE: 9261026]
18. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK, HEMO Study Group. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. American Journal of Nephrology 2001;21(4):280-288 [MEDLINE: 11509799] (Pubitemid 32757311)
19. Rostand SG. Coronary heart disease in chronic renal insufficiency: Some management considerations. Journal of American Society of Nephrology 2000;11(10):1948-1956 [MEDLINE: 11004228]
20. Salem MM. Hypertension in the hemodialysis population: A survey of 649 patients. American Journal of Kidney Diseases 1995;26(3):461-468 [MEDLINE: 7645554]
21. Sica DA, Gehr TW, Fernandez A. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease. Drug Safety 2000;22(5):350-359 [MEDLINE: 10830252] (Pubitemid 30261079)
22. Sica DA, Gehr TW. The pharmacokinetics and pharmacodynamics of angiotensin receptor blockers in end-stage renal disease. Journal of the Renin-Angiotensin-Aldosterone System 2002;3(4):247-252 [MEDLINE: 12584668]
23. Sica DA, Gehr TW. Calcium channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerations. Current Opinion in Nephrology & Hypertension 2003;112(2):123-131 [MEDLINE: 12589171]
24. United States Renal Data System. USRDS 1998 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD; April 1998.
25. US Renal Data System. USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2002.
26. United States Renal Data System. USRDS: the United States Renal Data System. American Journal of Kidney Diseases 2003;42(6 Suppl 5):1-230. [MEDLINE: 14655174]
27. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al."U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney International 1998;54(2):561-569 [MEDLINE: 9690224]
28. Zazgornik J, Biesenbach G, Forstenlehner M, Stummvoll K. Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT). Clinical Nephrology 1997;48(6):337-340 [MEDLINE: 9438090] (Pubitemid 27517424)